|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
2.820 +0.070 (+2.545%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -32.281% | -62.002% | -4.077% | -48.841% | -184.177% |
| ROAE (%) | N/A | N/A | N/A | -889.965% | -5089.784% |
| Return on Capital Employed (%) | N/A | N/A | N/A | -131.434% | -188.153% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 78.174% | 56.165% | 61.753% | N/A | N/A |
| EBITDA Margin (%) | -5244.565% | -2293.225% | -155.883% | N/A | N/A |
| Pre-tax Profit Margin (%) | -5851.412% | -2351.514% | -352.921% | N/A | N/A |
| Net Profit Margin (%) | -5851.412% | -2351.514% | -352.921% | N/A | N/A |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 0.192 X | 0.348 X | 0.834 X | 1.552 X | 2.363 X |
| Quick Ratio (X) | 0.186 X | 0.342 X | 0.528 X | 0.709 X | 2.005 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 492.495% | 301.330% | 134.873% | 114.232% | 77.194% |
| Total Debt / Total Assets (%) | 2.318% | 11.030% | 15.915% | 7.548% | 1.271% |
| Net Debt / Total Assets (%) | -56.127% | -38.339% | -19.102% | -26.691% | -50.498% |
| Total Debt / Shareholders' Funds (%) | N/A | N/A | N/A | N/A | 5.571% |
| Long Term Debt / Shareholders' Funds (%) | N/A | N/A | N/A | N/A | 3.809% |
| Net Debt / Shareholders' Funds (%) | N/A | N/A | N/A | N/A | -221.421% |
| Net Cash / (Debt) ($) | 257.016M | 311.599M | 401.413M | 1.253B | 2.699B |
| Net Cash / (Debt) per share ($) | 0.198 | 0.240 | 0.310 | 0.969 | 2.331 |
| Total Debt / Capital Employed (%) | N/A | N/A | N/A | 18.996% | 2.124% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 4983.801 Day | 7672.445 Day | 37454.412 Day | -- | -- |
| Receivables Turnover (Day) | 2134.599 Day | 309.237 Day | 224.142 Day | N/A | N/A |
| Payables Turnover (Day) | 11894.574 Day | 1749.433 Day | 5136.281 Day | N/A | N/A |
| Remarks: | Real time quote last updated: 27/03/2026 16:03 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -205,092 |
| %Change | -77.298% |
| EPS / (LPS) | RMB -0.160 |
| NBV Per Share (¥) | RMB -1.385 |